Relevium Provides Update on Newscope Transacion
28 janv. 2020 09h15 HE
|
Relevium Technologies Inc
MONTREAL, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an update on the...
Relevium’s CEO Provides an Open Shareholder Letter for 2020
19 déc. 2019 09h14 HE
|
Relevium Technologies Inc
MONTREAL, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an open letter to its...
Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company
08 nov. 2019 08h35 HE
|
Relevium Technologies Inc
MONTREAL, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a...
Relevium Enters Into LOI to Unlock Value of Wholly Owned Subsidiary BGX E-Health LLC and Announces Conference Call With CEO
29 oct. 2019 09h22 HE
|
Relevium Technologies Inc
MONTREAL, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce On October 25, 2019,...
Relevium Announces Intention to Spin-Out Pediatric Cannabis Subsidiary Biocannabix
19 sept. 2019 08h34 HE
|
Relevium Technologies Inc
MONTREAL, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces its intention to create a new,...
Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric Patients
10 juil. 2019 09h30 HE
|
Relevium Technologies Inc
MONTREAL, July 10, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has executed an...
Relevium to Hold Investor Call to Discuss LATAM Strategy June 28, 2019 at 1:00pm EST
19 juin 2019 08h30 HE
|
Relevium Technologies Inc
MONTREAL, June 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or...
Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, Colombia
13 juin 2019 09h54 HE
|
Relevium Technologies Inc
MONTREAL, June 13, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that Biocannabix...
Relevium Closes Private Placement Financing
11 juin 2019 17h51 HE
|
Relevium Technologies Inc
MONTREAL, June 11, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has closed a...
Relevium’s Biocannabix Executes LOI to Acquire 30% Interest in Weedsense, a Late Stage Applicant for Standard Processing and Medical Sales License
05 juin 2019 09h46 HE
|
Relevium Technologies Inc
MONTREAL, June 05, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly owned...